van Ruiten, Charlotte C ; van der Aart‐van der Beek, Annemarie B ; IJzerman, Richard G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360098/.  , 2021

van der Aart‐van der Beek, Annemarie B ; Cherney, David ; Laverman, Gozewijn D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360160/.  , 2021

van der Aart‐van der Beek, Annemarie B ; Clegg, Lindsay E ; Penland, Robert C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756541/.  , 2020

Van der Aart-van der Beek, Annemarie B ; de Boer, Rudolf A ; Heerspink, Hiddo J. L
https://research.rug.nl/en/publications/a9a32e12-037a-43d7-a263-d187273af629.  , 2022

van Ruiten, Charlotte C ; van der Aart-van der Beek, Annemarie B ; IJzerman, Richard G...
van Ruiten , C C , van der Aart-van der Beek , A B , IJzerman , R G , Nieuwdorp , M , Hoogenberg , K , van Raalte , D H & Heerspink , H J L 2021 , ' Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial ' , Diabetes, Obesity and Metabolism , vol. 23 , no. 8 , pp. 1851-1858 . https://doi.org/10.1111/dom.14410.  , 2021

van Ruiten, Charlotte C ; van der Aart-van der Beek, Annemarie B ; IJzerman, Richard G...
https://research.rug.nl/en/publications/59bdca93-36c4-452f-9139-f7df36899868.  , 2021

van der Aart-van der Beek, Annemarie B ; Cherney, David ; Laverman, Gozewijn D...
van der Aart-van der Beek , A B , Cherney , D , Laverman , G D , Stefansson , B , van Raalte , D H , Hoogenberg , K , Reyner , D , Li , Q , di Tanna , G L , Greasley , P J & Heerspink , H J L 2021 , ' Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials ' , Diabetes, Obesity and Metabolism , vol. 23 , no. 8 , pp. 1961-1967 . https://doi.org/10.1111/dom.14411.  , 2021

van der Aart-van der Beek, Annemarie B ; Koomen, Jeroen V ; Dekkers, Claire C.J...
van der Aart-van der Beek , A B , Koomen , J V , Dekkers , C C J , Barbour , S J , Boulton , D W , Gansevoort , R T , Greasley , P J , Abdul Gafor , A H , Laverman , G D , Li , Q , Lim , S K , Stevens , J , Vervloet , M G , Singh , S , Cattran , D C , Reich , H N , Cherney , D Z I & Heerspink , H J L 2021 , ' Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease ' , Clinical Pharmacokinetics , vol. 60 , no. 4 , pp. 517-525 . https://doi.org/10.1007/s40262-020-00956-1.  , 2021